Brigida Stanzione

654 total citations
24 papers, 411 citations indexed

About

Brigida Stanzione is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Brigida Stanzione has authored 24 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 15 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Brigida Stanzione's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (6 papers) and HER2/EGFR in Cancer Research (5 papers). Brigida Stanzione is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (6 papers) and HER2/EGFR in Cancer Research (5 papers). Brigida Stanzione collaborates with scholars based in Italy and Ukraine. Brigida Stanzione's co-authors include Grazia Arpino, Sabino De Placido, Michelino De Laurentiis, Vito Lorusso, Daniela Cianniello, Saverio Cinieri, R. Caputo, Michele Spina, Alessandro Del Conte and Alessandra Bearz and has published in prestigious journals such as International Journal of Molecular Sciences, Oncotarget and Cancer Treatment Reviews.

In The Last Decade

Brigida Stanzione

21 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brigida Stanzione Italy 9 218 163 150 132 39 24 411
Marianna Sirico Italy 12 199 0.9× 172 1.1× 125 0.8× 129 1.0× 31 0.8× 34 406
Ya-Ling Wei Taiwan 11 216 1.0× 256 1.6× 101 0.7× 101 0.8× 26 0.7× 19 448
Yanlong Shi China 12 158 0.7× 257 1.6× 129 0.9× 161 1.2× 32 0.8× 29 498
Nicole Liscia Italy 7 226 1.0× 131 0.8× 112 0.7× 104 0.8× 30 0.8× 29 374
María San Román Spain 11 182 0.8× 130 0.8× 98 0.7× 49 0.4× 41 1.1× 16 343
Ailing Zhong China 13 124 0.6× 192 1.2× 59 0.4× 104 0.8× 42 1.1× 29 355
Jason T. Godfrey United States 4 153 0.7× 224 1.4× 106 0.7× 100 0.8× 33 0.8× 5 404
Lais Osmani United States 5 238 1.1× 305 1.9× 261 1.7× 192 1.5× 34 0.9× 10 613
Woo-Young Kim South Korea 6 166 0.8× 267 1.6× 135 0.9× 76 0.6× 20 0.5× 6 416
Andrea Pretta Italy 12 272 1.2× 182 1.1× 102 0.7× 139 1.1× 61 1.6× 47 478

Countries citing papers authored by Brigida Stanzione

Since Specialization
Citations

This map shows the geographic impact of Brigida Stanzione's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brigida Stanzione with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brigida Stanzione more than expected).

Fields of papers citing papers by Brigida Stanzione

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brigida Stanzione. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brigida Stanzione. The network helps show where Brigida Stanzione may publish in the future.

Co-authorship network of co-authors of Brigida Stanzione

This figure shows the co-authorship network connecting the top 25 collaborators of Brigida Stanzione. A scholar is included among the top collaborators of Brigida Stanzione based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brigida Stanzione. Brigida Stanzione is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carlo, Elisa De, Elisa Bertoli, Brigida Stanzione, et al.. (2025). Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 26(2). 554–554. 2 indexed citations
2.
Bertoli, Elisa, Elisa De Carlo, Brigida Stanzione, et al.. (2025). Immunotherapy in Oncogene-Addicted NSCLC: Evidence and Therapeutic Approaches. International Journal of Molecular Sciences. 26(2). 583–583. 5 indexed citations
3.
Stanzione, Brigida, Alessandro Del Conte, Elisa Bertoli, et al.. (2025). Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Common Mutations: New Strategies. Cancers. 17(9). 1515–1515. 2 indexed citations
4.
Bearz, Alessandra, Elisa Bertoli, Brigida Stanzione, et al.. (2025). EML4-ALK: Update on ALK Inhibitors. International Journal of Molecular Sciences. 26(1). 308–308. 3 indexed citations
5.
Carlo, Elisa De, Elisa Bertoli, Brigida Stanzione, et al.. (2024). Navigating Therapeutic Challenges in BRAF-Mutated NSCLC: Non-V600 Mutations, Immunotherapy, and Overcoming Resistance. International Journal of Molecular Sciences. 25(23). 12972–12972.
6.
Bertoli, Elisa, Elisa De Carlo, Marcella Montico, et al.. (2024). EP.12B.14 Platinum-Pemetrexed Chemotherapy and Lorlatinib Combination in Advanced ALK Positive NSCLC Progressing to Lorlatinib: A Case Series. Journal of Thoracic Oncology. 19(10). S646–S646.
7.
Carlo, Elisa De, Elisa Bertoli, Mónica Schiappacassi, et al.. (2024). Case report: First evidence of impressive efficacy of modulated dose selpercatinib in a young Caucasian with ANK3-RET fusion-positive NSCLC. Frontiers in Oncology. 14. 1307458–1307458. 1 indexed citations
8.
Bertoli, Elisa, Elisa De Carlo, Debora Basile, et al.. (2023). Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications. International Journal of Molecular Sciences. 24(13). 10803–10803. 12 indexed citations
9.
Stanzione, Brigida, Alessandro Del Conte, Elisa Bertoli, et al.. (2023). Therapeutical Options in ROS1—Rearranged Advanced Non Small Cell Lung Cancer. International Journal of Molecular Sciences. 24(14). 11495–11495. 12 indexed citations
10.
Bearz, Alessandra, Elisa De Carlo, Alessandro Del Conte, et al.. (2022). The Change in Paradigm for NSCLC Patients with EML4–ALK Translocation. International Journal of Molecular Sciences. 23(13). 7322–7322. 3 indexed citations
11.
Carlo, Elisa De, Elisa Bertoli, Alessandro Del Conte, et al.. (2022). Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era. International Journal of Molecular Sciences. 23(12). 6477–6477. 10 indexed citations
12.
Carlo, Elisa De, Mónica Schiappacassi, Giacomo Pelizzari, et al.. (2021). Acquired EGFR C797G Mutation Detected by Liquid Biopsy as Resistance Mechanism After Treatment With Osimertinib: A Case Report. In Vivo. 35(5). 2941–2945. 5 indexed citations
13.
Pensabene, Matilde, Brigida Stanzione, Giuseppe Ciancia, et al.. (2018). It is no longer the time to disregard thyroid metastases from breast cancer: a case report and review of the literature. BMC Cancer. 18(1). 146–146. 17 indexed citations
14.
Berretta, Massimiliano, et al.. (2017). The Real Impact of Target Therapy in Breast Cancer Patients: Between Hope and Reality. Current Cancer Drug Targets. 18(5). 480–498. 4 indexed citations
15.
Bonotto, Marta, Lorenzo Gerratana, Massimo Di Maïo, et al.. (2016). Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis. The Breast. 31. 114–120. 38 indexed citations
16.
Berretta, Massimiliano, Carla Cavaliere, Lara Alessandrini, et al.. (2016). Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications. Oncotarget. 8(8). 14192–14220. 67 indexed citations
17.
Berretta, Massimiliano, Raffaele Di Francia, Brigida Stanzione, et al.. (2016). New treatment strategies for HIV-positive cancer patients undergoing antiblastic chemotherapy. Expert Opinion on Pharmacotherapy. 17(18). 2391–2403. 8 indexed citations
18.
Angelis, Carmine De, Monica Milano, Brigida Stanzione, et al.. (2013). Combination of Cytotoxic Drugs for Patients with HER2-Negative Metastatic Breast Cancer. INFM-OAR (INFN Catania). 3(1-2). 25–37. 2 indexed citations
19.
Stanzione, Brigida, et al.. (2012). Multiple metachronus proliferative fasciitis occurring in different anatomic regions: A case report and review of the literature. Pathology - Research and Practice. 208(2). 126–130. 8 indexed citations
20.
Laurentiis, Michelino De, Daniela Cianniello, R. Caputo, et al.. (2010). Treatment of triple negative breast cancer (TNBC): current options and future perspectives. Cancer Treatment Reviews. 36. S80–S86. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marianna Sirico Breakdown of academic impact, for papers by Ya-Ling Wei Breakdown of academic impact, for papers by Yanlong Shi Breakdown of academic impact, for papers by Nicole Liscia Breakdown of academic impact, for papers by María San Román Breakdown of academic impact, for papers by Ailing Zhong Breakdown of academic impact, for papers by Jason T. Godfrey Breakdown of academic impact, for papers by Lais Osmani Breakdown of academic impact, for papers by Woo-Young Kim Breakdown of academic impact, for papers by Andrea Pretta
Rankless by CCL
2026